Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Annals of Hematology|September 8, 2019
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphomaJun Ho Yi, Gyeong-Won Lee, Young Rok Do, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effectsIn Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.
Journal of Cancer|June 22, 2016
Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional ExperienceYoon Jung Oh, Seong Yoon Yi, Ki Hyang Kim, et al.
Oncotarget|March 27, 2016
Prognostic implications of PIK3CA amplification in curatively resected liposarcomaJoo Hoon Kim, Jae Seok Lee, Eo Jin Kim, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
World Journal of Gastroenterology|April 21, 2015
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinomaMin-Young Lee, Ki Sun Jung, Hae Su Kim, et al.
European Journal of Haematology|March 17, 2009
Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromesChan H Park, Bruce F Kimler, Seong Yoon Yi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2015
Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)Ji Yun Lee, Jong-Mu Sun, Dong Ryul Oh, et al.
JTO Clinical and Research Reports|December 2, 2024
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18Dae-Ho Choi, Miso Kim, Young Saing Kim, et al.
Bone Marrow Transplantation|December 6, 2020
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencingJae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung, et al.
Pageof 7